FORESITE CAPITAL MANAGEMENT IV, LLC Holdings
FORESITE CAPITAL MANAGEMENT IV, LLC is an investment fund managing more than 310.96M US dollars. The largest holdings include Kinnate Biopharma, Lyell Immunopharma and Aclaris Therapeutics. In Q3 2022 the fund bought assets of total value of 16.58M US dollars and sold assets of total value of 21.88M US dollars.
FORESITE CAPITAL MANAGEMENT IV, LLC portfolio value:
FORESITE CAPITAL MANAGEMENT IV, LLC quarter portfolio value change:
FORESITE CAPITAL MANAGEMENT IV, LLC 1 year portfolio value change:
FORESITE CAPITAL MANAGEMENT IV, LLC 3 years portfolio value change:
FORESITE CAPITAL MANAGEMENT IV, LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2018 | 64769000 | 15816000 |
| Q2 2018 | 90548000 | 36008000 |
| Q3 2018 | 35937000 | 1040000 |
| Q4 2018 | 8060000 | 85697000 |
| Q1 2019 | 41674000 | 14385000 |
| Q2 2019 | 109956000 | 39756000 |
| Q3 2019 | 41513000 | 78871000 |
| Q4 2019 | 27979000 | 107997000 |
| Q1 2020 | 4954000 | 121333000 |
| Q2 2020 | 135195000 | 13453000 |
| Q3 2020 | 218949000 | 9776000 |
| Q4 2020 | 448824000 | 27083000 |
| Q1 2021 | 167401000 | 151520000 |
| Q2 2021 | 272554000 | 216368000 |
| Q3 2021 | 12507000 | 31146000 |
| Q3 2022 | 16581000 | 21879000 |
FORESITE CAPITAL MANAGEMENT IV, LLC 13F holdings
| Stock |
|---|
| Portfolio share: 37.17% Portfolio value: 115.57M Avg. open price: N/A Current price: $7.05 P/L: N/A N/A Q4 2020 |
| Portfolio share: 23.57% Portfolio value: 73.3M Avg. open price: N/A Current price: $3.93 P/L: N/A Sold -24.71% shares Q3 2022 |
| Portfolio share: 14.21% Portfolio value: 44.19M Avg. open price: $7.26 Current price: $15.66 P/L: +115.80% Sold -3.14% shares Q2 2022 |
| Portfolio share: 8.13% Portfolio value: 25.27M Avg. open price: $16.34 Current price: $15.82 P/L: -3.20% Bought +2.32% shares Q1 2021 |
| Portfolio share: 8.01% Portfolio value: 24.90M Avg. open price: N/A Current price: $2.02 P/L: N/A Sold -0.46% shares Q2 2022 |
| Portfolio share: 5.33% Portfolio value: 16.58M Avg. open price: N/A Current price: $25.44 P/L: N/A N/A Q3 2022 |
| Portfolio share: 2.01% Portfolio value: 6.25M Avg. open price: $9.32 Current price: $4.17 P/L: -55.26% Sold -37.16% shares Q3 2020 |
| Portfolio share: 1.57% Portfolio value: 4.87M Avg. open price: N/A Current price: $2.36 P/L: N/A Sold -60.32% shares Q2 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $12.38 P/L: N/A Sold -100.00% shares Q3 2022 |
Showing TOP 9 FORESITE CAPITAL MANAGEMENT IV's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of FORESITE CAPITAL MANAGEMENT IV, LLC?
The biggest position of the FORESITE CAPITAL MANAGEMENT IV, LLC is Kinnate Biopharma Inc. (KNTE) with 37.17% portfolio share worth of 115.58M US dollars.
Top 5 FORESITE CAPITAL MANAGEMENT IV's holdings represent 91.09% of the portfolio:
- Kinnate Biopharma Inc. (KNTE) – 37.17%
- Lyell Immunopharma, Inc. (LYEL) – 23.57%
- Aclaris Therapeutics, Inc. (ACRS) – 14.21%
- Kura Oncology, Inc. (KURA) – 8.13%
- Pharvaris N.V. (PHVS) – 8.01%
Who is the portfolio manager of FORESITE CAPITAL MANAGEMENT IV, LLC?
The portfolio manager of the FORESITE CAPITAL MANAGEMENT IV, LLC is .
What is the total asset value of the FORESITE CAPITAL MANAGEMENT IV, LLC portfolio?
FORESITE CAPITAL MANAGEMENT IV, LLC total asset value (portfolio value) is 310.96M US dollars.
Who is ?
is the portfolio manager of the FORESITE CAPITAL MANAGEMENT IV, LLC.
What is (FORESITE CAPITAL MANAGEMENT IV, LLC) fund performance?
FORESITE CAPITAL MANAGEMENT IV's quarterly performance is -11.88%, annualy -46.70%. In the past 3 years, the value of 's portfolio has decreased by -145%.
What is the FORESITE CAPITAL MANAGEMENT IV, LLC CIK?
FORESITE CAPITAL MANAGEMENT IV's Central Index Key is 0001704132 .